The World Health Organization on Monday applauded newly published data by researchers at Oxford University and AstraZeneca on a potential coronavirus vaccine but cautioned that it’s still early and further evidence of its effectiveness is needed. For more coronavirus live updates: https://www.cnbc.com/2020/07/20/coronavirus-live-updates.html For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
The World Health Organization applauded newly published data by Oxford University and AstraZeneca on a potential coronavirus vaccine. However, the agency cautioned that it’s still early and further evidence of the vaccine’s effectiveness is needed.
“It is good news,” Dr. Mike Ryan, executive director of the WHO’s emergencies program, said at a press conference. “In generating T-cell responses and generating neutralizing antibodies, this is a positive result. But again, there is a long way to go. We now need to move into larger-scale real-world trials.”
The phase one trial had more than 1,000 participants. The researchers said the vaccine produced antibodies and killer T-cells, which combat the infection, that lasted at least two months. Though the update was promising, AstraZeneca’s stock was down more than 3%.
Isaac Bogoch, an infectious disease specialist and professor at the University of Toronto, said he was “extremely excited” by the new data. He said he doesn’t know why AstraZeneca’s stock is down on the news, adding, “I don’t understand the stock market, but I do understand infectious diseases.”
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
For info on the best credit cards go to CNBC Select: